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ABSTRACT 
The evolution of apolipoprotein B (Apob) has been intensely researched due to its importance 
during lipid transport. Mammalian full-length apob100 can be post-transcriptionally edited by the 
enzyme apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like complex-one 
(Apobec1) resulting in a truncated Apob, known as Apob48. Whilst both full-length and truncated 
forms of Apob are important for normal lipid homeostasis in mammals, there is no evidence for the 
presence of apob mRNA editing prior to the divergence of the mammals, yet, non-mammalian 
vertebrates appear to function normally with only Apob100. To date, the majority of the research 
carried out in non-mammalian vertebrates has focused on chickens with only a very limited number 
examining apob mRNA editing in fish. This study focused on the molecular evolution of Apobec1 
and Apob in order to ascertain if apob mRNA editing occurs in eels, a basal teleost which 
represents an evolutionarily important animal group. No evidence for the presence of Apobec1 or 
the ability for eel apob to be edited was found. However, an important link between mutant mice 
and the evident hypertriglyceridemia in the plasma of non-mammalian vertebrates was made. This 
study has provided imperative evidence to help bridge the evolutionary gap between fish and 
mammals and provides further support for the lack of apob mRNA editing in non-mammalian 
vertebrates.  
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1. INTRODUCTION 
The activation-induced deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-
like (Aid/Apobec) family is a group of proteins belonging to the cytidine deaminase superfamily. 
To date, one Aid and five Apobecs have been identified in mammals (Conticello, 2008) and only 
one Apobec has been found in non-mammalian species (with a few notable exceptions). As their 
name suggests, members of this family have the ability to edit RNA. Functions other than editing 
have also been reported for certain members of this family, e.g., Apobec2 has been linked to tissue 
regeneration (Powell et al., 2012), Apobec3 has antiviral properties (Harris and Liddament, 2004; 
Pham et al., 2005; Cullen, 2006) and Apobec4 is possibly involved in regulating spermatogenesis 
(Rogozin et al., 2005).  
 
Editing of apob mRNA results in the formation of a modified transcript in mammals, a nuclear 
event that occurs post-transcriptionally, yielding a truncated protein, Apob48 (Lau et al., 1991). 
During editing, Apobec replaces a cytidine (C) at the start of the 2153
rd
 codon (CAA) with a uridine 
(U) by hydrolytic deamination to produce a stop codon (UAA) resulting in translational termination 
(Navaratnam et al., 1993; Teng et al., 1993). This process is very precise, targeting a single cytidine 
hidden amongst the approximately 14,000 nucleotides that comprise the apob transcript. Research 
has shown that RNA editing has stringent cis-acting requirements that include sequence-specific 
elements located both upstream (the 5’ efficiency sequence, the A-rich region and the efficiency 
sequence) (Shah et al., 1991; Hersberger and Innerarity, 1998; Hersberger et al., 1999) and 
downstream (the mooring sequence and the 3’ efficiency sequence) (Backus and Smith, 1992; 
Richardson et al., 1998) of the editing site.  
 
Editing of the apob transcript is mediated by a multi-component enzyme complex consisting of an 
Apobec1 homodimer and an auxiliary factor called Apobec complementation factor (Acf) (see: 
Blanc and Davidson, 2010). The Acf recognises and attaches to the mooring sequence, positioning 
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the Apobec1 above the cytidine to be edited (Wedekind et al., 2003). The Apobec1 contains a 
cluster of residues that bind zinc which can activate a zinc-bound water molecule and initiate proton 
transfer (i.e. a free hydroxide ion). This in turn removes ammonia (deaminates) from the cytidine, 
converting it into uridine (Carter, 1995). Mutations in the mooring sequence can greatly reduce or 
completely abolish RNA editing (see: Adler and Hajduk, 1994; Chan et al., 1997; Davidson and 
Shelness, 2000 for in-depth reviews on the mechanisms and regulations of RNA editing). 
Consequently, the editing site and mooring region are highly conserved in mammals (Richardson et 
al., 1998).  
 
It was originally thought that apob editing was not only tissue specific (i.e. editing was thought to 
only occur in the intestine) but also specific to placental mammals. However, recent investigations 
have quashed both of these theories; apob editing has been discovered in the liver of rats and mice 
(Srivastava et al., 1992) and more recently, the detection of Apobec1 editing activity in non-
placental mammalian species (i.e. marsupials and monotremes (Fujino et al., 1999)) has seen the 
editing paradigm extended accordingly. Several other studies have examined the presence of 
Apobec1 and apob mRNA editing in lower vertebrates but, to date, there is no evidence indicating 
its presence prior to the divergence of the mammals (Blue et al., 1980; Tarugi et al., 1990; Teng and 
Davidson, 1992; Anant et al., 1998; Fujino et al., 1999; Dance et al., 2001; Conticello et al., 2005). 
The presence of two forms of Apob in mammals coupled with the seemingly normal functioning of 
non-mammalian vertebrates with only Apob100 begs an interesting question; what is the 
physiological relevance and benefit of having two forms of Apob? Several studies have genetically 
modified mice so that they exclusively synthesise either only Apob48 or only Apob100 (Farese et 
al., 1996; Hirano et al., 1996; Morrison et al., 1996; Nakamuta et al., 1996). These mice appear to 
develop and grow normally and are fertile. However, closer examination of serum lipid levels 
showed that the Apob100-only mice had elevated levels of triglycerides (hypertriglyceridemia), an 
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important issue especially for human health. This highlights a major functional difference between 
mammalian Apob100 and Apob48.  
 
The importance of normal lipid homeostasis and its evident link with the two mammalian forms of 
Apob has led to a growing amount of research investigating the benefits of each ApoB and the 
mechanisms of apob editing in mammals (Farese et al., 1996; Hirano et al., 1996; Morrison et al., 
1996; Nakamuta et al., 1996). Whilst a considerable amount of studies have been carried out on the 
chicken (Blue et al., 1980; Tarugi et al., 1990; Teng and Davidson, 1992), there has been minimal 
research into the presence of apob editing in any fish species and the consequences that a lack of 
editing may have on fish lipid homeostasis. This study focused on the molecular evolution of 
Apobec1 and Apob in order to ascertain whether apob mRNA editing occurs in anguillid eels, basal 
teleosts which represent an evolutionarily important animal group. Nucleotide, amino acid and 
partial genome alignments were complemented by phylogenic tree constructions and a synteny 
analysis. We conclude that having two forms of Apob is beneficial in terms of avoiding 
hypertriglyceridemia; as apparent from differences in lipid homeostasis between mammals and non-
mammalian vertebrates. 
 
 
2 METHODS 
2.1. Phylogenetic trees and alignments 
The amino acid sequences for Apob and Apobec1-4 from several mammalian and oviparous 
vertebrate species were obtained after a search of the National Center for Biotechnology 
Information (NCBI) database (http://www.ncbi.nlm.nih.gov/protein) (for accession numbers and 
species names see supplementary Table 1). Apobec5 is a very recent discovery (Severi et al., 2011) 
which has not yet been fully characterized or annotated in any species and was therefore omitted 
from this study. Searches were carried out in both the nucleotide and amino acid databases as well 
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as the whole genome databases. Failed Apobec1 searches were followed up by a BLAT (BLAST-
like alignment tool) search of the Genome Bioinformatics database 
(http://genome.ucsc.edu/index.html) which yielded possible remnant sequences in the zebrafish 
genome. The sequences for Anguilla australis were taken from a liver transcriptome (unpublished 
data). Where insufficient sequence data were available from the transcriptome, the A. anguilla 
genome was searched (http://www.zfgenomics.org/sub/eel). Whilst the full-length sequences were 
used for the analysis of the Apobecs, only the exon 26 (approximately 2500 amino acids), which 
includes the editing site, was used for the analysis of Apob due to its large size. The Neighbor-
Joining method (Saitou and Nei, 1987) was used to infer the evolutionary history of both the Apob 
sequences and the Apobec sequences. A bootstrap test (10,000 replicates) was carried out 
(Felsenstein, 1985). The evolutionary distances were computed using the p-distance method (Nei 
and Kumar, 2000). Phylogenetic tree construction was done using MEGA5 (Tamura et al., 2011). 
The amino acid sequences of Apob which span the Apobec1 editing site were aligned using CLC 
Sequence Viewer Version 6.3 to enable nucleotide differences in the efficiency sequence, editing 
site and mooring region to be observed.   
 
2.2. Synteny analysis & genome alignment. 
The synteny analysis of the human APOBEC1 genomic region in relation to  chimpanzee (Pan 
troglodytes), mouse (Mus musculus), sheep (Ovis aires), dog (Canis familiaris), elephant 
(Loxodonta Africana), opossum (Monodelphis domestica), chinese turtle (Pelodiscus sinensis), 
zebra finch (Taeniopygia guttata), flycatcher (Ficedula albicollis), duck (Anas platyrhynchos), 
chicken (Gallus gallus), turkey (Meleagris gallopavo), lizard (Anolis carolinensis), frog (Xenopus 
tropicalis), spotted gar (Lepisosteus oculatus), stickleback (Gasterosteus aculeatus), tetradon 
(Tetraodon nigroviridis), fugu (Takifugu rubripes), tilapia (Oreochromis niloticus), medaka 
(Oryzias latipes), amazon molly (Poecilia Formosa), platyfish (Xiphophorus maculatus), atlantic 
cod (Gadus morhua) and zebrafish (Danio rerio) was completed using Genomicus v86.01 web site 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
(Louis et al 2014). The synteny map was constructed with AlignView using human APOBEC1 
(ENSF00000111701) as the reference gene and the root species was expanded to Euteleostomi 
(~420 million years) to allow the inclusion of teleost species facilitate alignment, the synteny 
analysis was expanded to include two synteny blocks (FOXJ2 – SLC2A14 and PEX5 – C1R) to 
root all species alignments. Based on this synteny analysis, a physical alignment of genomic regions 
from human chromosome 12: 7,080,001 – 8,080,000, stickleback linkage group XX: 11,580,000 - 
12,100,000 and zebrafish chromosome 16: 13,800,000 – 14,540,000 was manually created using 
GNU Image Manipulation Program (v2.8 https://www.gimp.org). Sequence information and 
annotation were from Ensemble genomes Human (GRCh38), stickleback (BROADS1) and 
zebrafish (Zv9).  
 
3. RESULTS 
3.1. Apobec Phylogeny  
Searches of both the A. australis transcriptome and A. anguilla genome resulted in sequence 
information for only one of the four Apobecs, which showed greatest sequence identity with 
Apobec2 (Figure 1). A protein search of the NCBI database resulted in full sequence information 
for the Apobec genes from a variety of mammalian (placentals, monotremes and marsupials) and 
oviparous (birds, lizards, amphibians and fish) vertebrates. For most mammalian species, all four 
Apobec sequences were retrieved (except Apobec3 in marsupials) (Figure 1). Apobec1 was near-
universally absent in non-mammalian vertebrates except for Apobec1 in lizard and Apobec1-like in 
reptiles and some birds (Figure 1). Each member of the family grouped more closely with its 
orthologs found in other species than to the other enzymes found in the same species (except turtle 
Apobec3-like which clustered with the Apobec1s), i.e. all Apobec1 sequences across the species 
formed a cluster rather than all human Apobecs forming a cluster (Figure 1).    
 
3.2. Apob Phylogeny  
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The apob gene is highly conserved amongst the different vertebrate clades and their sequences 
therefore cluster together within the tree (Figure 2). Indeed, alignments of the amino acid sequences 
for exon 26 showed similarities greater than 75 % within the clusters of the tree (i.e., primates (96 
% homology between humans and gibbons); carnivores (85 % homology between cats and dogs); 
ungulates (82 % homology between bull and elephant); rodents (88 % homology between hamsters 
and rats); birds (85 % homology between chickens and flycatchers)). Even amongst the placental 
mammals, the two species separated by the greatest distance on the tree (human and rat) had 79 % 
homology. Although still high, once outside of the placental mammals the homology decreased 
quickly; there is 68 % identity between platypus and humans and 60 % homology between humans 
and turkeys. However, there is much lower homology between the fishes and the primates with 34 
% homology shared between zebrafish and humans across the approximately 2500 amino acids 
encoded by exon 26 of Apob.  
 
The single cytidine residue to which Apobec1 mRNA editing is targeted, also known as the editing 
site, is highly conserved amongst apob in all mammals, placental or otherwise (Figure 3). This 
cytidine forms the start of a glutamine codon. This glutamine codon is also present, in-frame, in the 
chicken, turkey, duck, turtle, alligator, cichlid (Haplochromis burtoni) and tilapia; however, there are 
between two and nine nucleotides that differ in the apob mooring region of these species compared 
to the highly homologous mooring region of mammals and between seven and thirteen differences 
in the efficiency sequences (Figure 3). The CAA sequence which encodes the glutamine appears to 
be out of frame in the lizard with an asparagine codon present at the editing site instead (Figure 3). 
Although the amino acid sequences from the lower vertebrates align well with the mammalian 
amino acid sequence both up- and down-stream of the editing region (providing credibility for the 
alignment), there is very little homology (ranging from approximately 8 – 66 % of amino acids) 
inside the area of focus. However, as editing occurs at the nucleotide level, the amino acid 
alignment is of little relevance.    
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3.3. Synteny analysis and genomic alignment. 
Among 17 protein-encoding mammalian genes, present in a block consisting of apobec1 and eight 
genes either side of apobec1, two synteny groups (FOXJ2 – SLC2A14 and PEX5 – C1R) were 
conserved within teleosts (Figure 4). Significantly, a nine-gene group that is linked and centers on 
apobec1 (nanog – acsm4) is not present in fish. Despite the presence of apobec1 in a number of 
non-mammalian species (turtle, zebra finch, flycatcher, duck and lizard), it appears that the synteny 
within which apobec1 is found is a mammal-specific grouping. To add further credence to the lack 
of apobec1 within the teleost lineage at this location, a specific genomic comparison between 
human and data-rich teleost genomes of stickleback and zebrafish shows that the common syntenic 
groups are separated by a 0.59Mb, 0.42Mb and 0.38Mb genomic region for each species 
respectively (Figure 5). Closer examination of the two teleost regions reveals a teleost-specific 
synteny grouping including seven common genes that occupies this space. 
 
4. DISCUSSION 
The evolutionary history of Apob and Apobec1-4 was inferred using sequences retrieved from the 
NCBI and Genome Bioinformatics databases as well as the A. australis transcriptome and A. 
anguilla genome. These inferences revealed a lack of apob mRNA editing in lower vertebrates.     
 
Surprisingly, recent research has revealed a homologue of the mammalian Apobec1 in reptiles 
(lizard: Severi et al., 2011; NB: the turtle, alligator, duck, zebrafinch and flycatcher sequences are 
predicted by automated computational analysis). Despite the presence of this homologue, there has 
been no evidence for apob mRNA editing outside of mammals suggesting that this gene arose by 
duplication independently well after the divergence of mammals and reptiles. Indeed, closer 
examination of the sequence revealed that the Apobec1 homologue was missing the C-terminal 
region that is required for apob mRNA editing (Severi et al., 2011). This study searched for eel 
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Apobec1 within transcriptome information gained from sequencing of the liver, as a gut 
transcriptome is currently unavailable; this may have lead to Apobec1 being overlooked due to the 
wrong tissue being examined. However, the genomes of all species of fish used in this study were 
also searched to no avail. Further support for the lack of Apobec1 comes from the results of synteny 
analysis. A whole block of nine mammalian genes which center on Apobec1 (nanog – acsm4) is 
missing in this linkage group of non-mammalian vertebrates. Interestingly, Acf was found in the 
transcriptome/genome of all species indicating that some of the editing complex is present; 
however, as with mammals, it appears Apobec1 is absolutely required for apob mRNA editing. 
 
Most studies agree that the single-domain cytidine deaminase, Apobec2, is the ancestral form from 
which all other Apobecs arose (Conticello et al., 2005; Rogozin et al., 2007; Conticello, 2008). 
Accordingly, Apobec2 was found in all species included in this study, and although not shown in 
this tree, in the case of most of the bony fishes (eels included), two distinct paralogues were present. 
These two paralogues more than likely reflect the genome duplication which is thought to have 
occurred around the origin of the ray-finned fishes (Taylor et al. 2003; Christoffels et al., 2004).  
 
No non-mammalian species were found to have a true Apobec3 (only an Apobec3-like gene). In 
fact, Apobec3 was not found in the possum, Tasmanian devil or platypus either, supporting the 
finding by LaRue and colleagues (2008) that Apobec3 arose from Apobec2 after the divergence of 
placental and non-placental mammals. Identified as the most recently diverged family, the 
Apobec3s appear to be still expanding at a rapid rate (Rogozin et al., 2005). The genomes of 
primates encode up to seven Apobec3 proteins on a single chromosome (Jarmuz et al., 2002; Zhang 
and Webb, 2004), compared to other placental mammals which average between two and four 
copies. This indicates a recent expansion in primates which is thought to be driven by selective 
pressure from retroviruses as primate Apobecs have been implicated in immune function 
(Conticello et al., 2005; Koito and Ikeda, 2012).   
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The discovery of Apobec4 occurred only recently (Rogozin et al., 2005) and little is known about 
its function (other than its transcript in the testis indicating a potential role in spermatogenesis). 
Despite its recent identification, the identification of Apobec4 in reptiles and birds, i.e. non-
mammalian species, indicates that Apobec4 diverged earlier than Apobec1 and 3. However, 
searches of the (nearly) complete genomes of several fish species failed to identify Apobec4, 
indicating that Apobec4 may have arisen prior to the divergence of the amniotes, possibly as a 
tetrapod-specific duplication. 
 
The lack of Apobec1 coupled with the low homology between mammalian Apob and non-
mammalian Apob within the sequence required for apob mRNA editing, supports the notion that 
apob mRNA editing does not occur in lower vertebrates (Blue et al., 1980; Tarugi et al., 1990; 
Teng and Davidson, 1992; Anant et al., 1998; Fujino et al., 1999; Dance et al., 2001; Conticello et 
al., 2005). The chicken, turkey and duck provide interesting models; although the Apobec1 has not 
been identified in any of these species, all of their Apob sequences contain the editing site. 
However, all three species have several nucleotides different from the mammalian mooring 
sequence and these have been shown to abolish mammalian Apobec1 editing abilities in vitro (Teng 
and Davidson, 1992). Another interesting case arises in the lizard. As mentioned above, an Apobec1 
orthologue has been recently discovered (Severi et al., 2011) but the apob mRNA editing site 
appears out-of-frame in the lizard apob gene. This, coupled with the lack of the C-terminus of the 
Apobec1 orthologue removes its ability to edit (Severi et al., 2011). Further, nucleotide differences 
in the mooring sequence of the lizard apob indicates that editing would likely not occur even in the 
presence of a functional Apobec1 because previous in vitro studies have shown that nearly all 
discrepancies in this eleven nucleotide sequence abolish apob mRNA editing (Shah et al., 1991; 
Teng and Davidson, 1992; Driscoll et al., 1993; Backus et al., 1994). The cichlid and tilapia also 
have the apob mRNA editing site (in-frame) present in their apob sequences. However, both species 
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have nine nucleotides different in the mooring region, so like the chicken, turkey and the lizard, it is 
very unlikely that it could be edited in the presence of a functional Apobec1.  
 
The benefit of having two forms of Apob has been a focus of mammalian lipid research over the 
last two decades (for in depth reviews see: Kim and Young, 1998; Veniant et al., 1999; Marschang 
and Herz, 2003). However, the results from the present study may provide an important link 
between mammals and non-mammalian vertebrates that has been previously unreported. Targeted 
mutagenesis of the apob gene has produced mice that exclusively synthesise either only apob48 or 
only apob100 (Farese et al., 1996). As mentioned above, both of these groups of mice appeared to 
develop and grow normally and were fertile. However, upon examination of their serum it was 
found that Apob48-only mice had significantly lower triglyceride levels than wild-type mice, while 
Apob100-only mice had significantly higher levels (Farese et al., 1996).  
 
It has been suggested that apob mRNA editing activity arose in order to ensure dietary triglycerides 
were sent specifically to the liver for further processing and were cleared quickly from circulation 
(Hodges and Scott, 1992). Indeed, Apob48 lacks the low density lipoprotein receptor binding site of 
Apob100 (Mahley, 1988; Segrest et al., 2001; Hinsdale et al., 2002) and therefore relies on 
apolipoprotein E (Apoe) and the highly expressed hepatic Apoe receptors for uptake (Mahley et al., 
1981; Linton et al., 1993). During mammalian intestinal chylomicron formation there is a 
convenient trade-off by which the reduced size of the Apob48 allows more Apoe to be associated 
with the lipoprotein. It is possible that non-mammalian vertebrates may not produce chylomicrons. 
Chickens produce molecules called portomicrons which have similar diameters and lipid 
compositions to mammalian chylomicrons but have Apob100 associated with them (Fraser et al., 
1986). In reptiles and fish, the nomenclature surrounding the lowest density lipoproteins is 
confusing and inconsistent with the terms chylomicron, portomicron and very-low density 
lipoprotein used interchangeably. Despite the erratic naming of these molecules in non-mammalian 
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vertebrates there has been no evidence to suggest that any Apob other than Apob100 is associated 
with these molecules. As mentioned above, Apob100 can be associated with chylomicrons (Farese 
et al., 1996; Hirano et al., 1996) but this results in elevated plasma triglyceride levels (Farese et al., 
1996). This increase in triglycerides is likely because the large size of the Apob100 displaces the 
amount of Apoe that can be incorporated into the lipoprotein, reducing the number of ligands 
available for binding and consequently increasing the time each lipoprotein is in circulation before 
being cleared. Also, the presence of Apob100 may reduce the accessibility of the triglycerides to 
lipase and thereby reduce lipolytic processing. These potential increases in Apob100 associated 
lipoprotein clearance times highlights an important physiological difference between mammalian 
Apob100 and Apob48. 
 
This apparent excess of triglycerides in the serum of Apob100-only mice may help to explain the 
evident hypertriglyceridemia seen in non-mammalian vertebrates (i.e. chickens: Kudzma et al., 
1975; Cho et al., 1984; Smith et al., 1985, and lizards: Knotkova et al., 2005; Lawton, 2005) in 
which only Apob100 has been confirmed. High levels of triglycerides have also been reported in 
anguillids (Larsson and Fange, 1969; Dave et al., 1975; Damsteegt et al., 2015) and evidence from 
this study suggests only Apob100 is present in eels. It is possible that in lower vertebrates the larger 
Apob100 is also affecting triglyceride transport from the gut resulting in hypertriglyceridemia. 
Further evidence that only Apob100 is present in eels comes from histological examination of the 
intestine. Feeding eels have a large amount of cytosolic fat in the enterocytes of their intestine 
(compared to non-feeding eels; see Figure 1 supplementary material), a pathological finding similar 
to that of mice with no Apob48 (Young et al., 1995) and humans with low levels of Apob 
(hypobetalipoproteinemia) or those that have normal levels of Apob but because of a mutation in 
microsomal triglyceride transfer protein can not synthesise Apob-containing lipoproteins 
(abetalipoproteinemia) (Gregg and Wetterau, 1994).  
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It appears that three components are necessary for successful editing of Apob – the presence of the 
editing site, a conserved mooring region and a functional Apobec1. However, using the current 
genomic data available we are still not able to ascertain which came first – Apobec1 or an editable 
Apob transcript. Presumably Apobec1 arose following a duplication event in early tetrapod 
evolution, preceding the mammalian-reptilian-avian split. It seems likely that the mooring region 
and Apobec1 have co-evolved and that Apobec1 neo-functionalised over time, but what were the 
implications of this? Did the ability to edit Apob give early mammals a fitness advantage which 
then lead to the fine-tuning of editing over time? As mentioned above, mammals that cannot edit 
Apob are disadvantaged, presenting with hypertriglyceridemia and the associated risks of this 
condition with heart disease. However, these detrimental effects do not appear to be problematic in 
non-mammalian vertebrates.   
 
This study has added to the almost overwhelming support that apob mRNA editing does not occur 
outside of mammals. It was concluded that only one of the Apobecs (Apobec2) is present in the 
shortfinned eel. The lack of Apobec1, the low homology in the mooring region, the dispersal of 
peptides throughout the Apob protein (after amino acid sequencing), the evident 
hypertriglyceridemia and the build-up of fat in the enterocytes of the intestine provide highly 
compelling evidence for the presence of only one form of Apob is in eels (not including those Apob 
forms resulting from post-translational cleavage) and that it likely corresponds to mammalian 
Apob100. This is also one of the first studies to provide the link between hypertriglyceridemia in 
lower vertebrates and the presence of only mammalian Apob100 homologues, a hugely important 
finding that may have future benefits for human health.  
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FIGURES 
Figure 1: A neighbor-joining phylogenetic tree constructed using the full-length deduced amino 
acid sequences from four members of the Apobec family. The number succeeding the animal name 
indicates which of the four members of the Apobec has been previously assigned to the sequence 
within the NCBI database. An * indicates that the sequence used is an Apobec-like gene. The tree is 
drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to 
infer the phylogenetic tree. The evolutionary distances were computed. Each branch forms a distinct 
cluster and has been circled accordingly. Scientific names and accession numbers can be found in 
Table 1 (Supplementary material). 
 
Figure 2: A neighbor-joining phylogenetic tree constructed using the amino acid sequences 
(approximately 2500 amino acids) encoded by exon 26 of Apob from sixteen mammalian species 
and twenty one non-mammalian vertebrates. The percentage of replicate trees in which the 
associated taxa clustered together in the bootstrap test (10000 replicates) is shown next to the 
branches. The tree is drawn to scale, with branch lengths in the same units as those of the 
evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were 
computed using the p-distance method and are in the units of the number of amino acid differences 
per site. The dotted line separates mammals (above) from oviparous vertebrates. Scientific names 
and accession numbers can be found in Table 1 (Supplementary material). 
 
Figure 3: The apob gene sequences of sixteen mammals aligned with that of twenty one non-
mammalian vertebrates. The codon involved in Apobec1 mRNA editing is shown, as is the 5’ 
efficiency sequence, A-rich region, efficiency sequence, spacer element and mooring region. 
Species names and accession numbers can be found in Table 1 (Supplementary material). 
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Figure 4: Genomic synteny map comparing orthologues of the APOBEC1 locus and the genes 
flanking it in humans (Homo sapiens), chimpanzee (Pan troglodytes), mouse (Mus musculus), 
sheep (Ovis aires), dog (Canis familiaris), elephant (Loxodonta Africana), opossum (Monodelphis 
domestica), Chinese turtle (Pelodiscus sinensis), zebra finch (Taeniopygia guttata), flycatcher 
(Ficedula albicollis), duck (Anas platyrhynchos), chicken (Gallus gallus), turkey (Meleagris 
gallopavo), lizard (Anolis carolinensis), frog (Xenopus tropicalis), spotted gar (Lepisosteus 
oculatus), stickleback (Gasterosteus aculeatus), tetradon (Tetraodon nigroviridis), fugu (Takifugu 
rubripes), tilapia (Oreochromis niloticus), medaka (Oryzias latipes), Amazon molly (Poecilia 
Formosa), platyfish (Xiphophorus maculatus), Atlantic cod (Gadus morhua) and zebrafish (Danio 
rerio). This map was obtained by using the genome browser Genomicus (v86.01) AlignView with 
the reference gene being Human APOBEC1 (ENSF00000111701), root species Euteleostomi (~420 
million years). Note that the direction of arrows indicates the gene orientation only in the reference 
species. Orthologs of each gene in other species are shown in a single column in the same colour. 
Genes are named after their human orthologs according to HUGO Gene Nomenclature Committee 
(HGNC).The chromosome number or genome fragment contig ID are indicated. 
 
Figure 5: Alignment of genomic regions from human (Homo sapiens) chromosome 12: 7,080,001 – 
8,080,000, stickleback (Gasterosteus aculeatus) linkage group XX: 11,580,000 - 12,100,000 and 
zebrafish (Danio rerio) chromosome 16: 13,800,000 – 14,540,000. Shaded boxes indicate common 
orthologues between all three species. Orthologous gene locations between zebrafish and 
stickleback are indicated by connected lines.  Genes are named after their human orthologs 
according to HUGO Gene Nomenclature Committee (HGNC). 
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Highlights 
 
 No evidence for Apob editing in anguillids, an evolutionarily important basal teleost 
 Lack of editing may cause hypertriglyceridemia evident in non-mammalian vertebrates 
 Link between the presence of only full-length Apob and changes in Apoe expression 
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